Our Focus is on Neuroscience, Oncology, and Cardio-renal Therapeutic areas

Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC) is where some of the best scientific minds in the world of pharma apply their innovative skills to investigating new drugs. Since 2007, OPDC has dedicated itself to the research and clinical development of products that could have a major impact on human health. OPDC develops promising drug candidates, starting with clinical trial management, and then planning the strategy for drug approval, marketing, and life cycle management to maximize a product’s full potential. Our focus is on neuroscience, oncology, and cardio-renal therapeutic areas. We have numerous promising drugs currently in the pipeline. In conjunction with Otsuka America Pharmaceutical, Inc, (OAPI), we have global strategies in place for the subsequent registration and marketing of these products. We also develop new products with other companies, For example, we are excited to be collaborating with Lundbeck, a Danish company, on a potential therapy for Alzheimer’s disease. There is a real need for new drugs to treat a condition for which no new treatments have been introduced in the last 10 years and which affects an estimated 44 million people worldwide.

44 million

Alzheimer’s disease affects an estimated 44 million people worldwide 
We have also acquired drugs, in various stages of development, that we believe could prove to be of benefit to patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The ambitious strategy of in-house development, collaborations and alliances, and perseverance, reflects Otsuka in the U.S.’s commitment to developing and launching medicines for better health worldwide.

2007

Otsuka Pharmaceutical Development & Commercialization, Inc. established
"Perseverance is the most influential aspect of Otsuka culture for me. I have always been disciplined. I like having my natural instinct to keep going at an issue endorsed and enhanced by the overall culture."
William H. Carson President & CEO, OPDC
William Carson

Meet our leadership team and discover their vision for our company

William H. CarsonA.B., M.D.
President & CEO, OPDC

RESEARCH & DEVELOPMENT

Otsuka’s extensive R&D program means that new medicines to treat cancer and mental health illness are on the horizon.

The talented people at Otsuka US have dreams, a passion to succeed, huge perseverance and a willingness to embrace our creative and innovative culture. We believe that we provide the perfect working environment for them to grow, but don’t just take our word for it. Let our employees tell you for themselves about why Otsuka US is such a great place to work.